Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses
about
Fragile X syndrome: loss of local mRNA regulation alters synaptic development and functionAdvances in the treatment of fragile X syndromeA pilot open label, single dose trial of fenobam in adults with fragile X syndrome.Dendritic mRNAs encode diversified functionalities in hippocampal pyramidal neuronsDysregulation and restoration of translational homeostasis in fragile X syndromeFragile X syndrome and targeted treatment trials.Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us.Increased expression of the PI3K enhancer PIKE mediates deficits in synaptic plasticity and behavior in fragile X syndrome.Haploinsufficiency of Cyfip1 produces fragile X-like phenotypes in miceThe G-quartet containing FMRP binding site in FMR1 mRNA is a potent exonic splicing enhancerFrom mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndromeGenetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalizationIncreased secreted amyloid precursor protein-α (sAPPα) in severe autism: proposal of a specific, anabolic pathway and putative biomarkerFMR1 transcript isoforms: association with polyribosomes; regional and developmental expression in mouse brainThe RNA binding and transport proteins staufen and fragile X mental retardation protein are expressed by rat primary afferent neurons and localize to peripheral and central axonsElongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTDMotor-induced transcription but sensory-regulated translation of ZENK in socially interactive songbirds.Enhanced expression of ADCY1 underlies aberrant neuronal signalling and behaviour in a syndromic autism model.From FMRP function to potential therapies for fragile X syndrome.Modeling psychiatric disorders at the cellular and network levelsCGG repeat in the FMR1 gene: size mattersRescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice.BC1 regulation of metabotropic glutamate receptor-mediated neuronal excitability.FMRP mediates mGluR5-dependent translation of amyloid precursor protein.Identifying intrinsic and extrinsic determinants that regulate internal initiation of translation mediated by the FMR1 5' leader.Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivoFragile X targeted pharmacotherapy: lessons learned and future directions.The RNA-binding protein fragile X-related 1 regulates somite formation in Xenopus laevis.Loss of the fragile X mental retardation protein decouples metabotropic glutamate receptor dependent priming of long-term potentiation from protein synthesis.Altered differentiation of neural stem cells in fragile X syndromeRNA exodus to Israel: RNA controlling function in the far reaches of the neuron. Workshop on RNA control on neuronal function.Increasing our understanding of human cognition through the study of Fragile X Syndrome.Deficits in LTP induction by 5-HT2A receptor antagonist in a mouse model for fragile X syndromeA 3' untranslated region variant in FMR1 eliminates neuronal activity-dependent translation of FMRP by disrupting binding of the RNA-binding protein HuRFragile X mental retardation protein expression in Alzheimer's diseaseIncreased long-term potentiation at medial-perforant path-dentate granule cell synapses induced by selective inhibition of histone deacetylase 3 requires Fragile X mental retardation proteinGenetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models.Fragile X mental retardation protein regulates heterosynaptic plasticity in the hippocampusOxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders
P2860
Q24608468-49AE76D9-CC0F-4843-9152-AD7A9E1024A6Q24632814-A698CB48-6625-4DA2-81A6-81F53005D457Q24654933-B5D0B5C1-FDE1-4B93-8946-C68B1F50A9C4Q25256777-9DE5466E-52A9-40CB-A1CC-F94DAA5941BAQ26782616-45AFB9B4-4181-46B3-833A-CB7642A0A7ABQ26865162-B938D30E-0323-4E08-B971-C48FDBE11432Q26866506-533A84EC-97A6-4973-B8C8-D7C4C3D5E7A6Q27320582-BAE4BECD-D636-4959-AA71-8084A1AED99FQ27325468-E24F73FC-ECC3-45D8-80B3-2FB342ED6FD5Q28118840-BC867F19-CB77-4445-B11C-676DCB840429Q28247567-C2BCC8D6-B3DB-4769-ABD0-FDCB5FB9E1F2Q28261563-3BAA9C7A-565B-44CF-97A3-3DBE17F0BC9EQ28396707-4FB46993-22DB-43C9-8A41-998882B9E8F9Q28478681-B551B93F-274B-4D42-BDB6-1D3F5CC85F2AQ28487767-E7A4E3A2-2272-4B4C-A721-2E64AB05A428Q28564973-0D17A2E2-29C3-4ADC-BEFA-48306F65C30DQ28585633-472E1D75-6CC1-466B-9F68-1FCECA88738BQ28649889-610A738D-4B14-4C73-96DD-488F56134490Q30362378-69B89076-035D-4918-9C14-C0C9C7AA75CCQ30410502-0F147013-301C-4EBA-94B6-7DE2CCE96D7EQ30446669-FC7BB1BB-C44D-46E0-8FE4-D93EE6A01B89Q30464036-C72D201D-1294-4857-8A97-AC3610C0BD76Q30488610-C6A3BCB0-2BE0-484D-A152-304D3A7A8508Q30494390-D0E8FC73-353C-406B-8FDF-F7C4BB35EEDCQ33273636-31AFE305-9359-45C5-AC90-4966E1D8A231Q33376873-76F2B7A4-359A-40F8-A627-1EE2654D20C1Q33592247-464ACC3D-3340-40BD-95C8-ACD43986D3E0Q33785983-D631DCC7-F5A0-4426-B3DA-E24D86A517A5Q33938446-4AC314DD-7A6E-4D6C-B57A-F38DA4DFC00BQ34108310-36B5558B-9D48-401D-AA23-E904336F6A6AQ34202047-B5919935-C5EF-4EC0-BB31-916312DA2A08Q34360790-D3712384-972C-40D1-948E-5F8B3C31C8C2Q34435526-78724DC9-FF0D-42CE-84DF-CAA1AF80A573Q34465437-34B15327-933C-4F16-88F9-18796C10B670Q34501231-23B3530F-9B95-4406-B2D2-33838E55A7F5Q34521866-7AA08C1D-0791-41E3-A2A1-A876E5237256Q34563831-6AEE26BB-4C24-4131-9CDF-FE2BF210C1E6Q34689960-21BCAEFE-B685-4150-80B2-0D226A31B41FQ34773158-DB09932C-E501-4F8B-896A-46467A131A47Q35009426-5C6B34A0-2A0B-4249-8417-F49715BFF5CB
P2860
Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Fragile X mental retardation p ...... rotein translation at synapses
@en
Fragile X mental retardation p ...... otein translation at synapses.
@nl
type
label
Fragile X mental retardation p ...... rotein translation at synapses
@en
Fragile X mental retardation p ...... otein translation at synapses.
@nl
prefLabel
Fragile X mental retardation p ...... rotein translation at synapses
@en
Fragile X mental retardation p ...... otein translation at synapses.
@nl
P2093
P2860
P356
P1476
Fragile X mental retardation p ...... rotein translation at synapses
@en
P2093
Aaron W Grossman
Chad C Spangler
Christine K Base
Fatima Hatia
Femke A E Lambers
Froukje E de Vries
Hooma Khaliq
Ivan Jeanne Weiler
Soong Ho Kim
Valerie Bertaina-Anglade
P2860
P304
17504-17509
P356
10.1073/PNAS.0407533101
P407
P577
2004-11-17T00:00:00Z